Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Serum homocysteine and stroke in atrial fibrillation.

    Friedman HS.

    Ann Intern Med. 2001 Feb 6;134(3):253-4. No abstract available. PMID: 11177349 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Homocysteine and the risk of stroke and thromboembolism in atrial fibrillation: an uncertain role.

    Nadar S, Lip GY.

    Stroke. 2003 Sep;34(9):e143; author reply e143-5. Epub 2003 Aug 21. No abstract available. PMID: 12933971 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation.

    Ay H, Arsava EM, Tokgözoglu SL, Ozer N, Saribas O.

    Stroke. 2003 Apr;34(4):909-12. Epub 2003 Feb 27.PMID: 12624219 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The association between hyperhomocysteinemia and ischemic stroke in patients with non-valvular atrial fibrillation.

    Loffredo L, Violi F, Fimognari FL, Cangemi R, Sbrighi PS, Sampietro F, Mazzola G, Di Lecce VN, D'Angelo A.

    Haematologica. 2005 Sep;90(9):1205-11.PMID: 16154844 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.

    Nadar S, Blann A, Lip GY.

    Blood Coagul Fibrinolysis. 2003 Jul;14(5):513-4. No abstract available. PMID: 12851541 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mechanisms of thrombogenesis in atrial fibrillation.

    Spence D.

    Lancet. 2009 Mar 21;373(9668):1006; author reply 1006-7. No abstract available. PMID: 19304011 [PubMed - indexed for MEDLINE]Related articles

    7.

    Fibrinogen as predictor of ischemic stroke in patients with non-valvular atrial fibrillation.

    Di Lecce VN, Loffredo L, Fimognari FL, Cangemi R, Violi F.

    J Thromb Haemost. 2003 Nov;1(11):2453-5. No abstract available. PMID: 14629486 [PubMed - indexed for MEDLINE]Related articles

    8.

    Homocysteine and risk of recurrent stroke.

    Boysen G, Brander T, Christensen H, Gideon R, Truelsen T.

    Stroke. 2003 May;34(5):1258-61. Epub 2003 Apr 17.PMID: 12702838 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Role of homocysteine for thromboembolic complication in patients with non-valvular atrial fibrilation.

    Cingozbay BY, Yiginer O, Cebeci BS, Kardesoglu E, Demiralp E, Dincturk M.

    Blood Coagul Fibrinolysis. 2002 Oct;13(7):609-13.PMID: 12439146 [PubMed - indexed for MEDLINE]Related articles

    10.

    Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.

    Roldán V, Marín F, Martínez JG, García-Herola A, Sogorb F, Lip GY.

    Am J Cardiol. 2005 Apr 1;95(7):881-2.PMID: 15781023 [PubMed - indexed for MEDLINE]Related articles

    11.

    Clopidogrel as antithrombotic therapy in atrial fibrillation.

    Veloso HH, de Paola AA.

    Chest. 2005 Jul;128(1):475; author reply 475. No abstract available. PMID: 16002984 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Oral anticoagulation and stroke in atrial fibrillation.

    Epstein EF, Natarajan I.

    N Engl J Med. 2003 Dec 11;349(24):2360-1; author reply 2360-1. No abstract available. PMID: 14674042 [PubMed - indexed for MEDLINE]Related articles

    13.

    Therapies for the prevention of stroke and other vascular events in atrial fibrillation and atrial flutter.

    Connolly SJ, Gillis AM.

    Can J Cardiol. 2005 Sep;21 Suppl B:71B-73B.PMID: 16239992 [PubMed - indexed for MEDLINE]Related articles

    14.

    Anticoagulation therapy in an elderly woman with atrial fibrillation.

    Marschalk A, Messinger-Rapport BJ.

    Cleve Clin J Med. 2001 Jun;68(6):561-6. Review. No abstract available. PMID: 11405619 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Plasma levels of coagulation and fibrinolysis markers in acute ischemic stroke patients with lone atrial fibrillation.

    Topcuoglu MA, Haydari D, Ozturk S, Ozcebe OI, Saribas O.

    Neurol Sci. 2000 Aug;21(4):235-40.PMID: 11214663 [PubMed - indexed for MEDLINE]Related articles

    17.

    Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine.

    Poli D, Antonucci E, Cecchi E, Marcucci R, Liotta AA, Cellai AP, Lenti M, Gensini GF, Abbate R, Prisco D.

    Stroke. 2005 Oct;36(10):2159-63. Epub 2005 Sep 22.PMID: 16179567 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Stroke prevention in atrial fibrillation.

    Verheugt FW.

    Neth J Med. 2006 Feb;64(2):31-3.PMID: 16517985 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Direct thrombin inhibitors: stroke prevention in atrial fibrillation and potential anti-inflammatory properties.

    Palagummi P, Saltzman H, Ezekowitz M.

    Am Heart J. 2005 Jan;149(1 Suppl):S32-5. Review. No abstract available. PMID: 15644791 [PubMed - indexed for MEDLINE]Related articles

    20.

    Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.

    Ferro D, Loffredo L, Polimeni L, Fimognari F, Villari P, Pignatelli P, Fuster V, Violi F.

    Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2763-8. Epub 2007 Sep 27.PMID: 17901373 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data